Linden Advisors’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Linden Advisors’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-250,000	Closed	-$2.61M	–	475
2023 Q1	$2.61M	Hold	250,000	–	–	0.03%	226
2022 Q4	$2.56M	Hold	250,000	–	–	0.03%	272
2022 Q3	$2.52M	Hold	250,000	–	–	0.02%	321
2022 Q2	$2.49M	Hold	250,000	–	–	0.02%	345
2022 Q1	$2.49M	Buy	+250,000	New	+$2.48M	0.02%	433

Linden Advisors's LVAC Position: Q2 2023 in Review

Linden Advisors sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 250,000 shares — an estimated $2.61M sold.

Linden Advisors first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $2.61M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Linden Advisors reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Linden Advisors sold 250,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $2.61M.
Linden Advisors first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Linden Advisors's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $2.61M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Linden Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.